Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katarina Blagovic

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Plos One|August 11, 2011
Microfluidic perfusion for regulating diffusible signaling in stem cellsKatarina Blagovic, Lily Y Kim, Joel Voldman
Integrative Biology : Quantitative Biosciences From Nano to Macro|October 27, 2011
Spatially organized in vitro models instruct asymmetric stem cell differentiationYi-Chin Toh, Katarina Blagovic, Hanry Yu, et al.
Current Opinion in Biotechnology|July 17, 2013
Engineering cell-cell signalingKatarina Blagovic, Emily S Gong, Daniel F Milano, et al.
Frontiers in Immunology|October 20, 2022
Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in miceKatarina Blagovic, Carolyne K Smith, Amritha Ramakrishnan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2022
Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8<sup>+</sup> T Cell Responses with Antitumor ActivityMatthew G Booty, Kelan A Hlavaty, Adam Stockmann, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Plos One|August 11, 2011
Microfluidic perfusion for regulating diffusible signaling in stem cellsKatarina Blagovic, Lily Y Kim, Joel Voldman
Integrative Biology : Quantitative Biosciences From Nano to Macro|October 27, 2011
Spatially organized in vitro models instruct asymmetric stem cell differentiationYi-Chin Toh, Katarina Blagovic, Hanry Yu, et al.
Current Opinion in Biotechnology|July 17, 2013
Engineering cell-cell signalingKatarina Blagovic, Emily S Gong, Daniel F Milano, et al.
Frontiers in Immunology|October 20, 2022
Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in miceKatarina Blagovic, Carolyne K Smith, Amritha Ramakrishnan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 29, 2022
Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8<sup>+</sup> T Cell Responses with Antitumor ActivityMatthew G Booty, Kelan A Hlavaty, Adam Stockmann, et al.
Pageof 1